Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Capsule camera test: which drink cleans the gut best?

NCT ID NCT07206329

Knowledge-focused Sponsor: Unidade Local de Saúde do Alto Ave, EPE Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two low-volume bowel preparations for capsule endoscopy, a less invasive alternative to traditional colonoscopy. 220 adults were randomly assigned to take either a 1-liter polyethylene glycol plus ascorbic acid solution or sodium picosulfate with magnesium citrate. The goal was to see which one cleans the bowel better and is easier for patients to tolerate.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Polyethylene Glycol plus Ascorbic Acid (PEG-Asc) and Sodium Picosulfate with Magnesium Citrate (SPMC)
What this could lead to
If successful, this study could help doctors choose the best bowel preparation for capsule endoscopy, making these less invasive tests more reliable and comfortable for patients.
What could go wrong
This is a completed study comparing two existing preparations, so it won't lead to a new treatment. The results may show only small differences, and individual patient tolerance can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

220 people

The number who actually took part.

Started

Jan 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Adults referred for capsule colonoscopy (CC) or pan-intestinal capsule endoscopy (PCE) * Ability to provide informed consent Exclusion Criteria * Contraindications to capsule endoscopy (e.g., known or suspected gastrointestinal obstruction, strictures, or fistulas) * Contraindications to the use of PEG-Asc or SPMC (e.g., severe renal impairment, congestive heart failure, electrolyte disturbances, hypersensitivity to study drugs) * Pregnancy or lactation * Inability to comply with the bowel preparation protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bowel preparation solution are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bowel preparation solution

Contacts and locations

Locations

  • Unidade Local de Saúde do Alto Ave (ULSAAVE)

    Guimarães, 4835-044, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.